Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism

Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness

(2018) Jacqueline Corrigan-Curay et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients

(2018) Pamela L. Lutsey et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis

(2018) Ghadeer K Dawwas et al.   Lancet Haematology

Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis

(2017) Jonathan AC Sterne et al.   HEALTH TECHNOLOGY ASSESSMENT

Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation

(2017) Beenish S. Manzoor et al.   PHARMACOTHERAPY

Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub‐Analysis From the PREFER in AF ( PRE vention o F Thromboembolic Events– E uropean R egistry in A trial F ibrillation)

(2017) Giuseppe Patti et al.   Journal of the American Heart Association

Dabigatran Compared With Rivaroxaban vs Warfarin—Reply

(2017) Anna L. Parks et al.   JAMA Internal Medicine

Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation

(2017) Faye L Norby et al.   Journal of Comparative Effectiveness Research

Heavy menstrual bleeding on Rivaroxaban - Comparison with Apixaban

(2016) Bethan Myers et al.   BRITISH JOURNAL OF HAEMATOLOGY

Antithrombotic Therapy for VTE Disease

(2016) Clive Kearon et al.   CHEST

Site-Level Variation in and Practices Associated With Dabigatran Adherence

(2015) Supriya Shore et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data

(2015) Kristen M. Sanfilippo et al.   THROMBOSIS RESEARCH

Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration

(2014) Supriya Shore et al.   AMERICAN HEART JOURNAL

Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

(2014) N. van Es et al.   BLOOD

Pharmacology and mechanisms of action of new oral anticoagulants

(2014) Joe-Elie Salem et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism

(2014) Simon Mantha et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis

(2014) Antonio Gómez-Outes et al.   THROMBOSIS RESEARCH

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

(2013) Sam Schulman et al.   CIRCULATION

Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban

(2013) Wolfgang Mueck et al.   CLINICAL PHARMACOKINETICS

Consistency of safety profile of new oral anticoagulants in patients with renal failure

(2013) J.-C. Lega et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data

(2012) Susan E. Andrade et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Patient-centered or ‘central’ patient: Raising the veil of ignorance over randomization

(2012) Anirban Basu   STATISTICS IN MEDICINE

Comparative effectiveness research: does one size fit all?

(2012) Lauren M. Kunz et al.   STATISTICS IN MEDICINE

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage

(2011) Margaret C. Fang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

An automated database case definition for serious bleeding related to oral anticoagulant use

(2011) Andrew Cunningham et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data

(2010) Renu K. Garg et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Observational Studies Analyzed Like Randomized Experiments

(2008) Miguel A. Hernán et al.   EPIDEMIOLOGY